🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hitoshi Kiyoi

Nagoya University

ORCID: 0000-0001-6382-9498
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy”.

FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy

Cancer Chemotherapy and Pharmacology(2001)10.1007/s002800100301
N/A
0.553DataRank · unranked
39 citations

Hitoshi Kiyoi, Yukiya Yamamoto, Yosuke Minami, Kazuhito Yamamoto, Ryuzo Ueda +2 more

Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group

The Lancet Haematology(2023)10.1016/s2352-3026(23)00072-8
N/A
0.505DataRank · unranked
28 citations

Yoshihiro Hatta, Chihaya Imai, Koichi Oshima, Yasuhiro Okamoto, Takao Deguchi +21 more

Recent advances in AML with mutated NPM1

International Journal of Hematology(2024)10.1007/s12185-024-03835-8
N/A
0.360DataRank · unranked
10 citations

Yoko Ushijima, Hitoshi Kiyoi, Yuichi Ishikawa

DNMT3A and IDH1/2 Mutations Are Stable During the Progression of Acute Myeloid Leukemia

Blood(2011)10.1182/blood.v118.21.1466.1466
N/A
0.225DataRank · unranked
2 citations

Hideaki Hoshino, Hitoshi Kiyoi, Tomoki Naoe, Rika Kihara

FIVE‐YEAR RESULTS OF A PHASE 2 STUDY OF CNS‐ORIENTED THERAPY WITH R‐CHOP FOR UNTREATED INTRAVASCULAR LARGE B‐CELL LYMPHOMA: FINAL ANALYSIS OF THE PRIMEUR‐IVL STUDY

Hematological Oncology(2023)10.1002/hon.3163_18
N/A
0DataRank · unranked
0 citations

Motoko Yamaguchi, Yachiyo Kuwatsuka, Kosei Matsue, Keijiro Sato, Shigeru Kusumoto +27 more